Disulfidptosis-related gene in acute myocardial infarction and immune microenvironment analysis: A bioinformatics

Nan Huang1, Chan Liu2, Zheng Liu1

  • 1Clinical Pharmacy, Xiangtan Center Hospital, Xiangtan, Hunan Province, PR China.

Plos One
|December 12, 2024
PubMed

Insights

Disulfidptosis-related genes (DSRGs) are dysregulated in acute myocardial infarction (AMI). This study identified seven key DSRGs with diagnostic and prognostic value for AMI, offering new insights for early detection.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Disulfidptosis is a novel cell death mechanism.
  • The role of disulfidptosis-related genes (DSRGs) in acute myocardial infarction (AMI) remains unclear.

Purpose of the Study:

  • To comprehensively analyze the role of DSRGs in AMI.
  • To identify potential diagnostic and prognostic biomarkers for AMI.

Main Methods:

  • Bioinformatics analysis of DSRGs in AMI.
  • Machine learning algorithms to identify hub genes.
  • In vitro validation using qPCR and cell models.

Main Results:

  • Sixteen differentially expressed DSRGs were identified in AMI.
  • Seven hub genes with significant diagnostic value (AUC = 0.940) were determined.
  • INF2 and CD2AP showed prognostic potential; hub genes correlated with the immune microenvironment.

Conclusions:

  • DSRGs are significantly altered in AMI.
  • Seven identified hub genes and a diagnostic model offer new avenues for early AMI diagnosis.
  • Further research into DSRGs' role in AMI pathogenesis and treatment is warranted.